Products for Research Use Only

CD9-binding peptide (TFA)

CAT: 0804-HY-P11444A-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P11444A-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CD9-binding peptide TFA is a CD9-binding peptide. CD9-binding peptide TFA inhibits the binding of EWI-2 to CD9. CD9-binding peptide TFA exhibits selective anti-migratory and anti-invasive activities against cancer cells. CD9-binding peptide TFA can be used for the study of cancer[1].
UNSPSC
12352209
Target
Others
Related Pathways
Others
Field of Research
Cancer
Purity
99.02
Smiles
OC([C@H](CC1=CN=CN1)NC([C@H](CC(C)C)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H](CCCNC(N)=N)NC([C@@H](NC([C@H](CO)NC([C@@H](N)CCCNC(N)=N)=O)=O)CC2=CN=CN2)=O)=O)=O)=O)=O)=O.O=C(O)C(F)(F)F.[x]
Molecular Formula
C45H79N21O10.xC2HF3O2
Molecular Weight
1074.24 (free base)
References & Citations
[1]Suwatthanarak T, et al. Inhibition of cancer-cell migration by tetraspanin CD9-binding peptide. Chem Commun (Camb) . 2021 May 18;57 (40) :4906-4909.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported